Related Experiment Videos
EP2 and EP4 prostanoid receptor signaling.
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721-0207, USA. regan@pharmacy.arzona.edu
Life Sciences
|November 11, 2003
Summary
Prostaglandin E(2) receptors EP(2) and EP(4) activate T-cell factor transcription. EP(4) uniquely induces early growth response factor-1 (EGR-1) via ERK signaling, impacting cancer and inflammation.
Area of Science:
- Molecular Biology
- Cellular Signaling
- G-protein coupled receptor research
Background:
- EP(2) and EP(4) are prostanoid receptors for prostaglandin E(2) (PGE(2)).
- Both receptors were initially known to activate Gs proteins and increase cyclic adenosine monophosphate (cAMP).
- Recent findings indicate EP(2) and EP(4) receptors can stimulate T-cell factor (Tcf) mediated transcriptional activity.
Purpose of the Study:
- To elucidate the distinct intracellular signaling pathways utilized by EP(2) and EP(4) receptors.
- To investigate the role of these pathways in transcriptional regulation.
- To explore the implications of EP(4) receptor signaling in cellular processes.
Main Methods:
- Investigating Tcf-mediated transcriptional activity.
- Analyzing the involvement of cAMP-dependent protein kinase (PKA) and phosphatidylinositol 3-kinase (PI3K) pathways.
- Assessing the activation of extracellular signal-regulated kinases (ERKs) 1 and 2.
- Measuring the induction of early growth response factor-1 (EGR-1) expression.
Main Results:
- EP(2) receptor stimulates Tcf activity primarily via PKA.
- EP(4) receptor stimulates Tcf activity via both PKA and PI3K.
- EP(4) receptor activates ERKs 1 and 2 through PI3K, leading to EGR-1 induction.
- EP(2) receptor does not activate ERKs 1 and 2 or induce EGR-1.
Conclusions:
- EP(2) and EP(4) receptors exhibit differential signaling capabilities beyond cAMP modulation.
- EP(4) receptor's activation of the PI3K/ERK/EGR-1 pathway suggests a role in cellular proliferation and survival.
- The induction of EGR-1 by EP(4) receptor signaling has potential implications for cancer and inflammatory diseases.